[1]
ASWINI S, BABU EZHUMALAI, HANUSHA V and SETHUMEENA S 2024. A STUDY ON THE PREVALENCE OF ADVERSE EFFECTS ASSOCIATED WITH SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR DAPAGLIFLOZIN IN A TERTIARY CARE CENTRE. Asian Journal of Pharmaceutical and Clinical Research. 17, 12 (Dec. 2024), 147–150. DOI:https://doi.org/10.22159/ajpcr.2024v17i12.52456.